LAVA THERAPEUTICS NV (LVTX) Stock Overview
USA - NASDAQ:LVTX - NL0015000AG6 - Common Stock
LVTX Key Statistics, Chart & Performance
The current stock price of LVTX is 1.58 USD. In the past month the price increased by 2.55%. In the past year, price decreased by -5.85%.
LVTX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.35 | 399.35B | ||
| AMGN | AMGEN INC | 12.66 | 148.66B | ||
| GILD | GILEAD SCIENCES INC | 14.51 | 139.40B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.91 | 99.51B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.45B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.28 | 59.42B | ||
| ARGX | ARGENX SE - ADR | 78.15 | 44.34B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.87 | 39.94B | ||
| INSM | INSMED INC | N/A | 30.24B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.44B | ||
| NTRA | NATERA INC | N/A | 22.21B | ||
| BIIB | BIOGEN INC | 8.58 | 20.14B |
Related stock screener links
About LVTX
Company Profile
LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company is headquartered in Utrecht, Utrecht and currently employs 34 full-time employees. The company went IPO on 2021-03-25. The firm focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Company Info
LAVA THERAPEUTICS NV
Yalelaan 60
Utrecht UTRECHT NL
Employees: 34
Phone: 31630003035
LAVA THERAPEUTICS NV / LVTX FAQ
What is the stock price of LAVA THERAPEUTICS NV today?
The current stock price of LVTX is 1.58 USD. The price decreased by -1.86% in the last trading session.
What is the ticker symbol for LAVA THERAPEUTICS NV stock?
The exchange symbol of LAVA THERAPEUTICS NV is LVTX and it is listed on the Nasdaq exchange.
On which exchange is LVTX stock listed?
LVTX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for LAVA THERAPEUTICS NV stock?
8 analysts have analysed LVTX and the average price target is 1.4 USD. This implies a price decrease of -11.56% is expected in the next year compared to the current price of 1.58. Check the LAVA THERAPEUTICS NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is LAVA THERAPEUTICS NV worth?
LAVA THERAPEUTICS NV (LVTX) has a market capitalization of 41.57M USD. This makes LVTX a Nano Cap stock.
How many employees does LAVA THERAPEUTICS NV have?
LAVA THERAPEUTICS NV (LVTX) currently has 34 employees.
What are the support and resistance levels for LAVA THERAPEUTICS NV (LVTX) stock?
LAVA THERAPEUTICS NV (LVTX) has a support level at 1.52 and a resistance level at 1.62. Check the full technical report for a detailed analysis of LVTX support and resistance levels.
Is LAVA THERAPEUTICS NV (LVTX) expected to grow?
The Revenue of LAVA THERAPEUTICS NV (LVTX) is expected to decline by -100% in the next year. Check the estimates tab for more information on the LVTX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy LAVA THERAPEUTICS NV (LVTX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of LVTX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of LVTX, evaluating the profitability, health, valuation and growth aspects
- LAVA THERAPEUTICS NV (LVTX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- LAVA THERAPEUTICS NV (LVTX) Sales and EPS estimates to see what analysts future expectations are.
- LAVA THERAPEUTICS NV (LVTX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- LAVA THERAPEUTICS NV (LVTX) Insider and Institutional Ownership to learn about the owners and their transactions.
- LAVA THERAPEUTICS NV (LVTX) Stock Chart to make your own analysis
- LAVA THERAPEUTICS NV (LVTX) Latest news and press-releases to stay up to date.
Does LAVA THERAPEUTICS NV (LVTX) stock pay dividends?
LVTX does not pay a dividend.
When does LAVA THERAPEUTICS NV (LVTX) report earnings?
LAVA THERAPEUTICS NV (LVTX) will report earnings on 2025-12-08.
What is the Price/Earnings (PE) ratio of LAVA THERAPEUTICS NV (LVTX)?
LAVA THERAPEUTICS NV (LVTX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.05).
What is the Short Interest ratio of LAVA THERAPEUTICS NV (LVTX) stock?
The outstanding short interest for LAVA THERAPEUTICS NV (LVTX) is 0.56% of its float. Check the ownership tab for more information on the LVTX short interest.
LVTX Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to LVTX. When comparing the yearly performance of all stocks, LVTX turns out to be only a medium performer in the overall market: it outperformed 64.43% of all stocks.
LVTX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to LVTX. While LVTX seems to be doing ok healthwise, there are quite some concerns on its profitability.
LVTX Financial Highlights
Over the last trailing twelve months LVTX reported a non-GAAP Earnings per Share(EPS) of -1.05. The EPS decreased by -15.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -69.12% | ||
| ROE | -190.76% | ||
| Debt/Equity | 0 |
LVTX Forecast & Estimates
8 analysts have analysed LVTX and the average price target is 1.4 USD. This implies a price decrease of -11.56% is expected in the next year compared to the current price of 1.58.
For the next year, analysts expect an EPS growth of 7.87% and a revenue growth -100% for LVTX